艾博抗Abcam 人RTK磷酸化抗体芯片-膜结合型（71个靶

ab193662是一种磷酸化人受体酪氨酸激酶阵列，可用于同时检测细胞和组织裂解液中的71种磷酸化人受体酪氨酸激酶(RTK)。

• 货号：ab193662
• 中文名称：人RTK磷酸化抗体芯片-膜结合型（71个靶点）
• 英文名称：Human RTK Phosphorylation Antibody Array -Membrane (71 Targets)
• 规格：1x2Membranes,1x4Membranes,1x8Membranes
• 品牌：艾博抗Abcam
• 产地：美国/英国/中国杭州
• 货期：热销品现货，其他请咨询
• 资质：Abcam一级代理商
• 产品详情：ab193662可用于同时检测细胞和组织裂解液中的71种磷酸化人类受体酪氨酸激酶(RTK)。靶点：ALB1、ACK1、ALK、Axl、Blk、BMX、Btk、Csk、Dtk、EGFR、EphA1、EphA2、EphA3、EphA4、EphA5、EphA6、EphA7、EphA8、EphB1、EphB2、EphB3、EphB4、EphB6、ErbB2、ErbB3、ErbB4、FAK、FER、FGFR1、FGFR2、FGFR2（α亚型）、Fgr、FRK、Fyn、Hck、HGFR、IGF-I R、胰岛素受体（CD220）、Itk、JAK1、JAK2、JAK3、LCK、LTK、Lyn、MATK、M-CSFR、MUSK、NGFR（TNFRSF16）、PDGFR-α、PDGFR-β、PYK2 RET、ROR1、ROR2、ROS、RYK、SCF R (CD117/c-kit)、SRMS、SYK、Tec、Tie-1、Tie-2、TNK1、TRKB、TXK、Tyk2、TYRO10 (DDR2/TKT)、VEGFR2、VEGFR3、ZAP70。REACH授权：Abcam过去未曾、将来也不打算为客户使用含有欧盟授权清单（附件十四）物质的产品申请REACH授权。客户有责任自行核实其预期用途是否需要申请REACH授权以及任何其他相关授权。
• 英文别名：HTK, MYK1, TYRO11, EPHB4, Ephrin type-B receptor 4, Hepatoma transmembrane kinase, Tyrosine-protein kinase TYRO11, EPH, EPHT, EPHT1, EPHA1, Ephrin type-A receptor 1, hEpha1, EPH tyrosine kinase, EPH tyrosine kinase 1, Erythropoietin-producing hepatoma receptor, Tyrosine-protein kinase receptor EPH, CD331, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR, FGFR1, Fibroblast growth factor receptor 1, FGFR-1, Basic fibroblast growth factor receptor 1, Fms-like tyrosine kinase 2, N-sam, Proto-oncogene c-Fgr, bFGF-R-1, FLT-2, ERBB, ERBB1, HER1, EGFR, Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, Tyrosine-protein kinase Lck, Leukocyte C-terminal Src kinase, Lymphocyte cell-specific protein-tyrosine kinase, Protein YT16, Proto-oncogene Lck, T cell-specific protein-tyrosine kinase, p56-LCK, LSK, LCK, C20orf148, SRMS, Tyrosine-protein kinase Srms, TRKB, NTRK2, BDNF/NT-3 growth factors receptor, GP145-TrkB, Neurotrophic tyrosine kinase receptor type 2, TrkB tyrosine kinase, Tropomyosin-related kinase B, Trk-B, Tyrosine-protein kinase Fyn, Proto-oncogene Syn, Proto-oncogene c-Fyn, Src-like kinase, p59-Fyn, SLK, FYN, CD340, HER2, MLN19, NEU, NGL, ERBB2, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, MLN 19, CD140b, PDGFR, PDGFR1, PDGFRB, Platelet-derived growth factor receptor beta, PDGF-R-beta, PDGFR-beta, Beta platelet-derived growth factor receptor, Beta-type platelet-derived growth factor receptor, CD140 antigen-like family member B, Platelet-derived growth factor receptor 1, PDGFR-1, ACVRLK1, ALK1, ACVRL1, Activin receptor type-1-like, Activin receptor-like kinase 1, Serine/threonine-protein kinase receptor R3, TGF-B superfamily receptor type I, ALK-1, SKR3, TSR-I, UFO, AXL, Tyrosine-protein kinase receptor UFO, AXL oncogene, Tyrosine-protein kinase Blk, B lymphocyte kinase, p55-Blk, BLK, Cytoplasmic tyrosine-protein kinase BMX, Bone marrow tyrosine kinase gene in chromosome X protein, Epithelial and endothelial tyrosine kinase, NTK38, ETK, BMX, ABL, JTK7, ABL1, Tyrosine-protein kinase ABL1, Abelson murine leukemia viral oncogene homolog 1, Abelson tyrosine-protein kinase 1, Proto-oncogene c-Abl, p150, Tyrosine-protein kinase CSK, C-Src kinase, Protein-tyrosine kinase CYL, CSK, ECK, EPHA2, Ephrin type-A receptor 2, Epithelial cell kinase, Tyrosine-protein kinase receptor ECK, ETK, ETK1, HEK, TYRO4, EPHA3, Ephrin type-A receptor 3, EPH-like kinase 4, Tyrosine-protein kinase TYRO4, Tyrosine-protein kinase receptor ETK1, EK4, hEK4, Human embryo kinase, Eph-like tyrosine kinase 1, HEK8, SEK, TYRO1, EPHA4, Ephrin type-A receptor 4, EPH-like kinase 8, Tyrosine-protein kinase TYRO1, Tyrosine-protein kinase receptor SEK, EK8, hEK8, BSK, EHK1, HEK7, TYRO4, EPHA5, Ephrin type-A receptor 5, Brain-specific kinase, EPH homology kinase 1, EPH-like kinase 7, EHK-1, EK7, hEK7, EHK2, HEK12, EPHA6, Ephrin type-A receptor 6, EPH homology kinase 2, EPH-like kinase 12, EHK-2, EK12, EHK3, HEK11, EPHA7, Ephrin type-A receptor 7, EPH homology kinase 3, EPH-like kinase 11, EHK-3, EK11, hEK11, EEK, HEK3, KIAA1459, EPHA8, Ephrin type-A receptor 8, EPH- and ELK-related kinase, EPH-like kinase 3, Tyrosine-protein kinase receptor EEK, EK3, hEK3, ELK, EPHT2, HEK6, NET, EPHB1, Ephrin type-B receptor 1, EPH tyrosine kinase 2, EPH-like kinase 6, Neuronally-expressed EPH-related tyrosine kinase, Tyrosine-protein kinase receptor EPH-2, EK6, hEK6, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5, EPHB2, Ephrin type-B receptor 2, Developmentally-regulated Eph-related tyrosine kinase, ELK-related tyrosine kinase, EPH tyrosine kinase 3, EPH-like kinase 5, Renal carcinoma antigen NY-REN-47, Tyrosine-protein kinase TYRO5, Tyrosine-protein kinase receptor EPH-3, EK5, hEK5, ETK2, HEK2, TYRO6, EPHB3, Ephrin type-B receptor 3, EPH-like tyrosine kinase 2, Embryonic kinase 2, Tyrosine-protein kinase TYRO6, EPH-like kinase 2, EK2, hEK2, Ephrin type-B receptor 6, HEP, Tyrosine-protein kinase-defective receptor EPH-6, EPHB6, HER3, ERBB3, Receptor tyrosine-protein kinase erbB-3, Proto-oncogene-like protein c-ErbB-3, Tyrosine kinase-type cell surface receptor HER3, FAK, FAK1, PTK2, Focal adhesion kinase 1, FADK 1, Focal adhesion kinase-related nonkinase, Protein phosphatase 1 regulatory subunit 71, Protein-tyrosine kinase 2, p125FAK, pp125FAK, FRNK, PPP1R71, TYK3, FER, Tyrosine-protein kinase Fer, Feline encephalitis virus-related kinase FER, Fujinami poultry sarcoma/Feline sarcoma-related protein Fer, Proto-oncogene c-Fer, Tyrosine kinase 3, p94-Fer, CD332, BEK, KGFR, KSAM, FGFR2, Fibroblast growth factor receptor 2, FGFR-2, K-sam, Keratinocyte growth factor receptor, SRC2, FGR, Tyrosine-protein kinase Fgr, Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog, Proto-oncogene c-Fgr, p55-Fgr, p58-Fgr, p58c-Fgr, PTK5, RAK, FRK, Tyrosine-protein kinase FRK, FYN-related kinase, Nuclear tyrosine protein kinase RAK, Protein-tyrosine kinase 5, Tyrosine-protein kinase HCK, Hematopoietic cell kinase, Hemopoietic cell kinase, p59-HCK/p60-HCK, p59Hck, p61Hck, HCK, CD221, Insulin-like growth factor 1 receptor, Insulin-like growth factor I receptor, IGF-I receptor, IGF1R, CD220, Insulin receptor, IR, INSR, EMT, LYK, ITK, Tyrosine-protein kinase ITK/TSK, Interleukin-2-inducible T-cell kinase, Kinase EMT, T-cell-specific kinase, Tyrosine-protein kinase Lyk, IL-2-inducible T-cell kinase, Tyrosine-protein kinase JAK3, Janus kinase 3, Leukocyte janus kinase, JAK-3, L-JAK, JAK3, TYK1, LTK, Leukocyte tyrosine kinase receptor, Protein tyrosine kinase 1, JTK8, LYN, Tyrosine-protein kinase Lyn, Lck/Yes-related novel protein tyrosine kinase, V-yes-1 Yamaguchi sarcoma viral related oncogene homolog, p53Lyn, p56Lyn, CTK, HYL, MATK, Megakaryocyte-associated tyrosine-protein kinase, CSK homologous kinase, Hematopoietic consensus tyrosine-lacking kinase, Protein kinase HYL, Tyrosine-protein kinase CTK, CHK, CD115, FMS, CSF1R, Macrophage colony-stimulating factor 1 receptor, CSF-1 receptor, Proto-oncogene c-Fms, CSF-1-R, CSF-1R, M-CSF-R, Muscle-specific tyrosine-protein kinase receptor, MuSK, Muscle-specific kinase receptor, MUSK, CD271, TNFRSF16, NGFR, Tumor necrosis factor receptor superfamily member 16, Gp80-LNGFR, Low affinity neurotrophin receptor p75NTR, Low-affinity nerve growth factor receptor, Low-affinity nerve growth factor receptor p75NGFR, Low-affinity nerve growth factor receptor p75NGR, p75 ICD, NGF receptor, FAK2, PYK2, RAFTK, PTK2B, Protein-tyrosine kinase 2-beta, Calcium-dependent tyrosine kinase, Calcium-regulated non-receptor proline-rich tyrosine kinase, Cell adhesion kinase beta, Focal adhesion kinase 2, Proline-rich tyrosine kinase 2, Related adhesion focal tyrosine kinase, CADTK, CAK-beta, CAKB, FADK 2, CDHF12, CDHR16, PTC, RET51, RET, Proto-oncogene tyrosine-protein kinase receptor Ret, Cadherin family member 12, Proto-oncogene c-Ret, NTRKR1, ROR1, Inactive tyrosine-protein kinase transmembrane receptor ROR1, NTRKR2, ROR2, Tyrosine-protein kinase transmembrane receptor ROR2, JTK5A, RYK, Tyrosine-protein kinase RYK, CD117, SCFR, KIT, Mast/stem cell growth factor receptor Kit, Piebald trait protein, Proto-oncogene c-Kit, Tyrosine-protein kinase Kit, p145 c-kit, v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, PBT, Tyrosine-protein kinase SYK, Spleen tyrosine kinase, p72-Syk, SYK, PSCTK4, TEC, Tyrosine-protein kinase Tec, TIE, TIE1, Tyrosine-protein kinase receptor Tie-1, CD202b, TIE2, VMCM, VMCM1, TEK, Angiopoietin-1 receptor, Endothelial tyrosine kinase, Tunica interna endothelial cell kinase, Tyrosine kinase with Ig and EGF homology domains-2, Tyrosine-protein kinase receptor TEK, Tyrosine-protein kinase receptor TIE-2, p140 TEK, hTIE2, Non-receptor tyrosine-protein kinase TNK1, CD38 negative kinase 1, TNK1, Non-receptor tyrosine-protein kinase TYK2, TYK2, CD309, FLK1, VEGFR2, KDR, Vascular endothelial growth factor receptor 2, VEGFR-2, Fetal liver kinase 1, Kinase insert domain receptor, Protein-tyrosine kinase receptor flk-1, FLK-1, VEGFR3, FLT4, Vascular endothelial growth factor receptor 3, VEGFR-3, Fms-like tyrosine kinase 4, Tyrosine-protein kinase receptor FLT4, FLT-4, CD140a, PDGFR2, RHEPDGFRA, PDGFRA, Platelet-derived growth factor receptor alpha, PDGF-R-alpha, PDGFR-alpha, Alpha platelet-derived growth factor receptor, Alpha-type platelet-derived growth factor receptor, CD140 antigen-like family member A, CD140a antigen, Platelet-derived growth factor alpha receptor, Platelet-derived growth factor receptor 2, PDGFR-2, PTK4, RLK, TXK, Tyrosine-protein kinase TXK, Protein-tyrosine kinase 4, Resting lymphocyte kinase, CD331, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR, FGFR1, Fibroblast growth factor receptor 1, FGFR-1, Basic fibroblast growth factor receptor 1, Fms-like tyrosine kinase 2, N-sam, Proto-oncogene c-Fgr, bFGF-R-1, FLT-2
• 详细参数：与人靶标EPHB4反应（参见靶标数据）应用多重蛋白检测（参见反应性数据）有关已验证物种和应用组合的信息，请参见下方的反应性数据表。样品类型组织裂解液、细胞裂解液浓度范围
• 成分和储存条件：运输条件：蓝冰；适宜短期储存条件：-20°C；适宜长期储存条件：-20°C；储存信息：-20°C
• 重组蛋白序列概况：
• 重组蛋白真实序列：
• 靶点概况：受体酪氨酸激酶能够与相邻细胞上的跨膜Ephrin-B家族配体广泛结合，从而引发接触依赖性的双向信号传导。受体下游的信号通路称为正向信号传导，而Ephrin配体下游的信号通路称为反向信号传导。它与其同源配体/功能性配体EFNB2共同参与细胞黏附和迁移的调控，并在心脏形态发生、血管生成、血管重塑和通透性调节中发挥核心作用。EPHB4介导的前向信号传导控制细胞排斥和与表达EFNB2的细胞分离。

说明：所有内容为机器翻译，仅供参考，产品具体信息以Abcam厂家说明为准。